Individual versus combined diagnostic performances of non-invasive CMR and invasive EMB in troponin-positive patients without coronary artery disease
© Baccouche et al; licensee BioMed Central Ltd. 2009
Published: 28 January 2009
Only few data is available regarding a direct comparison of both non-invasive CMR and invasive EMB with respect to conformity of procedure-derived diagnoses in the same patients.
The aim of this study was to elucidate the diagnostic performance of non-invasive cardiovascular magnetic resonance imaging (CMR) and endomyocardial biopsy (EMB) in patients with troponin-I (TnI) positive acute chest pain in the absence of significant coronary artery disease (CAD).
1174 consecutive patients who were admitted with TnI-positive acute chest pain between 03/2004 and 07/2007 underwent coronary angiography. In 1012 patients (86%) significant CAD (stenosis >50%) was detected as underlying reason for the acute chest pain. In 82 out of the remaining 162 patients without significant CAD, further workup was performed including both CMR and EMB.
CMR alone enabled a diagnosis in 66/82 (80%) and EMB alone in 72/82 (88%) patients (p = 0.31). Myocarditis was the most frequent diagnosis by both CMR and EMB in this cohort and was detected with a higher frequency by EMB (58% vs. 81%; p < 0.001). With the combined approach comprising CMR and EMB, a final diagnosis could be established applying the "Believe-The-Positive-Rule" in 78/82 patients (95%). This combined approach turned out to yield more diagnoses than either CMR (p < 0.001) or EMB (p = 0.03) as single techniques, respectively. Comparison of diagnostic CMR procedures with the corresponding diagnostic EMBs demonstrated a substantial match of diagnoses (kappa = 0.70).
CMR and EMB have good diagnostic performances as single techniques in patients with TnI-positive acute chest pain in the absence of CAD. The combined application of CMR and EMB yields a considerable diagnostic synergy by overcoming some limitations of CMR and EMB as individually applied techniques.
This article is published under license to BioMed Central Ltd.